← The Wire
RYTMNasdaq
RHYTHM PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1649904
Transforms lives with precision medicines for rare neuroendocrine diseases, focusing on MC4R agonists
red 8-K · 90d⚡ Elevated coverage
$6.06B
Market cap
$110.04
Last close
+0.2%
1D
+8.5%
5D
828K
Volume
Price · last 39 sessions+28.6%
May 4L $84.35 · H $110.04Jun 29
196
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 5, 202610-Q10-QNov 4, 202510-Q10-QAug 5, 202510-Q10-QMay 7, 202510-Q10-QNov 6, 202410-Q10-QAug 6, 202410-Q10-QMay 7, 202410-Q10-QNov 8, 202310-Q10-QAug 1, 202310-Q10-QMay 2, 202310-Q10-QNov 8, 202210-Q10-QAug 3, 202210-Q10-QMay 3, 202210-Q10-QNov 2, 202110-Q10-QAug 3, 202110-Q10-QMay 3, 202110-Q10-QNov 2, 202010-Q10-QAug 3, 202010-Q10-QMay 4, 202010-Q10-QNov 1, 201910-Q10-QJul 29, 201910-Q10-QMay 3, 201910-Q10-QNov 9, 201810-Q10-QAug 8, 201810-Q10-QMay 14, 201810-Q10-QNov 14, 2017
Insider Activity
In the 90 days to Mar 4, 2026: 3 sold $3.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | German Christopher PaulCorporate Controller & CAO | Sell | 5,614 | $89.56 | $503K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,692 | $100.92 | $171K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,308 | $100.27 | $131K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 800 | $102.10 | $82K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 585 | $103.28 | $60K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,200 | $99.42 | $119K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,069 | $103.00 | $110K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 900 | $101.70 | $92K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 200 | $103.84 | $21K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 200 | $100.52 | $20K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 800 | $98.99 | $79K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 400 | $97.67 | $39K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 292 | $96.26 | $28K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $100.10 | $10K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 2,266 | $98.37 | $223K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 400 | $99.44 | $40K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $100.85 | $10K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,913 | $102.66 | $196K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 700 | $103.68 | $73K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $104.76 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance